2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one
TL;DR: 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one (CAS 55256-06-9) is a chemical compound with molecular formula C10H16N2O4 and molecular weight 228.11 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
8-hydroxy-7-(3-hydroxypropyl)-3,4,5,8-tetrahydro-2H-pyrrolo[3,4-b][1,4]oxazepin-6-one
Also Known As: 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one, 6H-Pyrrolo[3,4-b][1,4]oxazepin-6-one, 2,3,4,5,7,8-hexahydro-8-hydroxy-7-(3-hydroxypropyl)-, 2,3,4,5,7,8-Hexahydro-8-hydroxy-7- -6H-pyrrolo[3,4-b][1,4]oxazepin-6-one, 8-hydroxy-7-(3-hydroxypropyl)-2H,3H,4H,5H,6H,7H,8H-pyrrolo[3,4-b][1,4]oxazepin-6-one, 8-hydroxy-7-(3-hydroxypropyl)-3,4,5,8-tetrahydro-2H-pyrrolo[3,4-b][1,4]oxazepin-6-one
| Molecular Formula | C10H16N2O4 |
|---|---|
| Molecular Weight | 228.11 g/mol |
| LogP | -1.0 |
| Topological Polar Surface Area | 82.0 Ų |
| Hydrogen Bond Donors | 3 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Exact Mass | 228.11101 |
| Heavy Atoms | 16 |
| Complexity | 316.0 |
Chemical Identifiers
| CAS Number | 55256-06-9 |
|---|---|
| SMILES | C1CNC2=C(C(N(C2=O)CCCO)O)OC1 |
| InChIKey | YANKOFDRMXGUKA-UHFFFAOYSA-N |
Product Overview
2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one (CAS 55256-06-9), with molecular formula C10H16N2O4 and molecular weight 228.11 g/mol. IUPAC: 8-hydroxy-7-(3-hydroxypropyl)-3,4,5,8-tetrahydro-2H-pyrrolo[3,4-b][1,4]oxazepin-6-one.
Chemical Property Profile of 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one
Property Insights of 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one
The XLogP value of -1.0 indicates that 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one is hydrophilic (water-soluble), making it suitable for aqueous formulations and biological assay applications. The TPSA of 82.0 Ų falls within the moderate polarity range, balancing permeability and solubility for 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one. Following Lipinski's Rule of Five, 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one has 3 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one?
The CAS number of 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one is 55256-06-9.
What is the molecular formula of 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one?
The molecular formula of 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one is C10H16N2O4.
What is the molecular weight of 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one?
The molecular weight of 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one is 228.11 g/mol.
Where can I buy 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one?
You can request a quote for 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one?
Yes, KEHONG BIO provides custom synthesis services for 2,3,4,5,7,8-Hexahydro-8-hydroxy-7-(3-hydroxypropyl)-6H-pyrrolo[3,4-b][1,4]oxazepin-6-one and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.